- Home
- NRO vs OABI Comparison
NRO vs OABI Comparison
Compare NRO & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- OABI
- Stock Information
- Founded
- NRO 2003
- OABI 2012
- Country
- NRO United States
- OABI United States
- Employees
- NRO N/A
- OABI N/A
- Industry
- NRO Finance/Investors Services
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- NRO Finance
- OABI Health Care
- Exchange
- NRO Nasdaq
- OABI Nasdaq
- Market Cap
- NRO 199.6M
- OABI 227.4M
- IPO Year
- NRO N/A
- OABI N/A
- Fundamental
- Price
- NRO $3.20
- OABI $1.62
- Analyst Decision
- NRO
- OABI Strong Buy
- Analyst Count
- NRO 0
- OABI 3
- Target Price
- NRO N/A
- OABI $6.67
- AVG Volume (30 Days)
- NRO 239.4K
- OABI 610.1K
- Earning Date
- NRO 01-01-0001
- OABI 11-11-2025
- Dividend Yield
- NRO 11.41%
- OABI N/A
- EPS Growth
- NRO N/A
- OABI N/A
- EPS
- NRO N/A
- OABI N/A
- Revenue
- NRO N/A
- OABI $23,027,000.00
- Revenue This Year
- NRO N/A
- OABI N/A
- Revenue Next Year
- NRO N/A
- OABI $48.74
- P/E Ratio
- NRO N/A
- OABI N/A
- Revenue Growth
- NRO N/A
- OABI 6.05
- 52 Week Low
- NRO $2.51
- OABI $1.22
- 52 Week High
- NRO $3.45
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- NRO 46.21
- OABI 45.86
- Support Level
- NRO $3.19
- OABI $1.58
- Resistance Level
- NRO $3.25
- OABI $1.90
- Average True Range (ATR)
- NRO 0.04
- OABI 0.09
- MACD
- NRO -0.01
- OABI 0.02
- Stochastic Oscillator
- NRO 38.46
- OABI 22.54
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.